Webinar | October 26, 2023

Bridging The Distance To Large-Scale GMP Manufacturing Of Viral Vectors

Source: Cytiva

Over the past decade, gene therapy has made significant advancements, garnering multiple recent approvals. In several of these commercial processes for viral vector manufacturing, iCELLis™ bioreactors are utilized. The industry is constantly evolving, and the technology designed to expedite the development of life-changing medical treatments for patients has evolved in tandem.

In this webinar, AGC Biologics shares its journey to the successful implementation of iCELLis™ bioreactors and how they have used this technology to establish and support its AAV and lentivirus platforms.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma